Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.917 SEK | +0.77% | -0.86% | +33.09% |
Sales 2024 * | 266M 24.61M | Sales 2025 * | 136M 12.55M | Capitalization | 695M 64.27M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -72M -6.66M | EV / Sales 2024 * | 1.49 x |
Net cash position 2024 * | 298M 27.53M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.12 x |
P/E ratio 2024 * |
-1.72
x | P/E ratio 2025 * |
-2.88
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
Latest transcript on Alligator Bioscience AB
1 day | +0.77% | ||
1 week | -0.86% | ||
Current month | +1.89% | ||
1 month | -6.81% | ||
3 months | -28.25% | ||
6 months | +141.32% | ||
Current year | +33.09% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Dixon
BRD | Director/Board Member | 63 | 19-05-08 |
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.917 | +0.77% | 446,324 |
24-05-02 | 0.91 | +1.11% | 800,269 |
24-04-30 | 0.9 | -2.70% | 413,942 |
24-04-29 | 0.925 | 0.00% | 195,044 |
24-04-26 | 0.925 | +1.09% | 808,960 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 11:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.09% | 64.35M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ATORX Stock